|
Volumn 16, Issue 3, 2001, Pages 257-265
|
Cardiovascular dysfunction in Parkinsonian disorders
|
Author keywords
Autonomic failure; Lewy body disease; Multiple system atrophy; Orthostatic hypotension; Parkinson's disease; Progressive supranuclear palsy
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIPARKINSON AGENT;
BROMOCRIPTINE;
CARBIDOPA;
CATECHOL METHYLTRANSFERASE INHIBITOR;
DESMOPRESSIN;
DIURETIC AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
EPHEDRINE;
ERYTHROPOIETIN;
FLUDROCORTISONE;
LEVODOPA;
MIDODRINE;
MONOAMINE OXIDASE B INHIBITOR;
OCTREOTIDE;
PERGOLIDE;
SELEGILINE;
TOLCAPONE;
VASODILATOR AGENT;
YOHIMBINE;
ATROPHY;
AUTONOMIC DYSFUNCTION;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
HEART RATE;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
LEWY BODY;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
PROGRESSIVE SUPRANUCLEAR PALSY;
PROSTATE HYPERTROPHY;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASES;
HEART RATE;
HUMANS;
PARKINSON DISEASE;
|
EID: 0035211821
PISSN: 03935264
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (36)
|